-
2
-
-
46849101214
-
Tuberculosis
-
cited; Available from
-
WHO. Tuberculosis. Fact Sheet No 104. 2007. [cited; Available from: http://www.who.int/mediacentre/factsheets/fs104/en/].
-
(2007)
Fact Sheet
, Issue.104
-
-
-
3
-
-
0028153628
-
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
-
Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 March 2 (9) (1994) 698-702
-
(1994)
JAMA
, vol.271
, Issue.March 2 9
, pp. 698-702
-
-
Colditz, G.A.1
Brewer, T.F.2
Berkey, C.S.3
Wilson, M.E.4
Burdick, E.5
Fineberg, H.V.6
-
4
-
-
33750319222
-
Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity
-
Dietrich J., Andersen C., Rappuoli R., Doherty T.M., Jensen C.G., and Andersen P. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immunol 177 November 1 (9) (2006) 6353-6360
-
(2006)
J Immunol
, vol.177
, Issue.November 1 9
, pp. 6353-6360
-
-
Dietrich, J.1
Andersen, C.2
Rappuoli, R.3
Doherty, T.M.4
Jensen, C.G.5
Andersen, P.6
-
5
-
-
33845989506
-
The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis
-
Andersen C.S., Dietrich J., Agger E.M., Lycke N.Y., Lovgren K., and Andersen P. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis. Infect Immun 75 1 (2007) 408-416
-
(2007)
Infect Immun
, vol.75
, Issue.1
, pp. 408-416
-
-
Andersen, C.S.1
Dietrich, J.2
Agger, E.M.3
Lycke, N.Y.4
Lovgren, K.5
Andersen, P.6
-
6
-
-
33749511016
-
Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice
-
Giri P.K., Verma I., and Khuller G.K. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice. J Infect 53 5 (2006) 350-356
-
(2006)
J Infect
, vol.53
, Issue.5
, pp. 350-356
-
-
Giri, P.K.1
Verma, I.2
Khuller, G.K.3
-
7
-
-
20044361834
-
Recent developments in tuberculosis vaccines
-
Haile M., and Kallenius G. Recent developments in tuberculosis vaccines. Curr Opin Infect Dis 18 3 (2005) 211-215
-
(2005)
Curr Opin Infect Dis
, vol.18
, Issue.3
, pp. 211-215
-
-
Haile, M.1
Kallenius, G.2
-
8
-
-
14244264779
-
Recent advances in the development of live, attenuated bacterial vectors
-
Roland K.L., Tinge S.A., Killeen K.P., and Kochi S.K. Recent advances in the development of live, attenuated bacterial vectors. Curr Opin Mol Ther 7 1 (2005) 62-72
-
(2005)
Curr Opin Mol Ther
, vol.7
, Issue.1
, pp. 62-72
-
-
Roland, K.L.1
Tinge, S.A.2
Killeen, K.P.3
Kochi, S.K.4
-
9
-
-
0036801656
-
Bacterial infectious disease control by vaccine development
-
Curtiss III R. Bacterial infectious disease control by vaccine development. J Clin Invest 110 8 (2002) 1061-1066
-
(2002)
J Clin Invest
, vol.110
, Issue.8
, pp. 1061-1066
-
-
Curtiss III, R.1
-
10
-
-
0019819989
-
Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain
-
Formal S.B., Baron L.S., Kopecko D.J., Washington O., Powell C., and Life C.A. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun 34 3 (1981) 746-750
-
(1981)
Infect Immun
, vol.34
, Issue.3
, pp. 746-750
-
-
Formal, S.B.1
Baron, L.S.2
Kopecko, D.J.3
Washington, O.4
Powell, C.5
Life, C.A.6
-
11
-
-
0343978503
-
Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella
-
VanCott J.L., Staats H.F., Pascual D.W., Roberts M., Chatfield S.N., Yamamoto M., et al. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol 156 February 15 (4) (1996) 1504-1514
-
(1996)
J Immunol
, vol.156
, Issue.February 15 4
, pp. 1504-1514
-
-
VanCott, J.L.1
Staats, H.F.2
Pascual, D.W.3
Roberts, M.4
Chatfield, S.N.5
Yamamoto, M.6
-
12
-
-
0035852273
-
Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers
-
Bumann D., Metzger W.G., Mansouri E., Palme O., Wendland M., Hurwitz R., et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 20 December 12 (5-6) (2001) 845-852
-
(2001)
Vaccine
, vol.20
, Issue.December 12 5-6
, pp. 845-852
-
-
Bumann, D.1
Metzger, W.G.2
Mansouri, E.3
Palme, O.4
Wendland, M.5
Hurwitz, R.6
-
13
-
-
34247362129
-
Ability of SPI2 mutant of S. Typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans
-
Khan S., Chatfield S., Stratford R., Bedwell J., Bentley M., Sulsh S., et al. Ability of SPI2 mutant of S. Typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans. Vaccine 25 May 22 (21) (2007) 4175-4182
-
(2007)
Vaccine
, vol.25
, Issue.May 22 21
, pp. 4175-4182
-
-
Khan, S.1
Chatfield, S.2
Stratford, R.3
Bedwell, J.4
Bentley, M.5
Sulsh, S.6
-
14
-
-
0033964153
-
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers
-
Tacket C.O., Sztein M.B., Wasserman S.S., Losonsky G., Kotloff K.L., Wyant T.L., et al. Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun 68 3 (2000) 1196-1201
-
(2000)
Infect Immun
, vol.68
, Issue.3
, pp. 1196-1201
-
-
Tacket, C.O.1
Sztein, M.B.2
Wasserman, S.S.3
Losonsky, G.4
Kotloff, K.L.5
Wyant, T.L.6
-
15
-
-
28644438573
-
Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers
-
Kirkpatrick B.D., McKenzie R., O'Neill J.P., Larsson C.J., Bourgeois A.L., Shimko J., et al. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine 24 January 12 (2) (2006) 116-123
-
(2006)
Vaccine
, vol.24
, Issue.January 12 2
, pp. 116-123
-
-
Kirkpatrick, B.D.1
McKenzie, R.2
O'Neill, J.P.3
Larsson, C.J.4
Bourgeois, A.L.5
Shimko, J.6
-
16
-
-
19944374089
-
Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters
-
Stratford R., McKelvie N.D., Hughes N.J., Aldred E., Wiseman C., Curtis J., et al. Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters. Infect Immun 73 1 (2005) 362-368
-
(2005)
Infect Immun
, vol.73
, Issue.1
, pp. 362-368
-
-
Stratford, R.1
McKelvie, N.D.2
Hughes, N.J.3
Aldred, E.4
Wiseman, C.5
Curtis, J.6
-
17
-
-
33947231293
-
Oral attenuated Salmonella enterica Serovar Typhimurium vaccine expressing codon-optimized HIV Type 1 Gag enhanced intestinal immunity in mice
-
Tsunetsugu-Yokota Y., Ishige M., and Murakami M. Oral attenuated Salmonella enterica Serovar Typhimurium vaccine expressing codon-optimized HIV Type 1 Gag enhanced intestinal immunity in mice. AIDS Res Hum Retrov 23 2 (2007) 278-286
-
(2007)
AIDS Res Hum Retrov
, vol.23
, Issue.2
, pp. 278-286
-
-
Tsunetsugu-Yokota, Y.1
Ishige, M.2
Murakami, M.3
-
18
-
-
14744293582
-
Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli
-
Lasaro M.O., Luiz W.B., Sbrogio-Almeida M.E., and Ferreira L.C. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine 23 March 31 (19) (2005) 2430-2438
-
(2005)
Vaccine
, vol.23
, Issue.March 31 19
, pp. 2430-2438
-
-
Lasaro, M.O.1
Luiz, W.B.2
Sbrogio-Almeida, M.E.3
Ferreira, L.C.4
-
19
-
-
0030900746
-
Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase
-
Hess J., Dietrich G., Gentschev I., Miko D., Goebel W., and Kaufmann S.H. Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase. Infect Immun 65 4 (1997) 1286-1292
-
(1997)
Infect Immun
, vol.65
, Issue.4
, pp. 1286-1292
-
-
Hess, J.1
Dietrich, G.2
Gentschev, I.3
Miko, D.4
Goebel, W.5
Kaufmann, S.H.6
-
20
-
-
0032900382
-
Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A
-
Ward S.J., Douce G., Figueiredo D., Dougan G., and Wren B.W. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. Infect Immun 67 5 (1999) 2145-2152
-
(1999)
Infect Immun
, vol.67
, Issue.5
, pp. 2145-2152
-
-
Ward, S.J.1
Douce, G.2
Figueiredo, D.3
Dougan, G.4
Wren, B.W.5
-
21
-
-
0025778866
-
The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis
-
Content J., de la Cuvellerie A., De Wit L., Vincent-Levy-Frebault V., Ooms J., and De Bruyn J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun 59 9 (1991) 3205-3212
-
(1991)
Infect Immun
, vol.59
, Issue.9
, pp. 3205-3212
-
-
Content, J.1
de la Cuvellerie, A.2
De Wit, L.3
Vincent-Levy-Frebault, V.4
Ooms, J.5
De Bruyn, J.6
-
22
-
-
22944433876
-
The success and failure of BCG-implications for a novel tuberculosis vaccine
-
Andersen P., and Doherty T.M. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3 8 (2005) 656-662
-
(2005)
Nat Rev Microbiol
, vol.3
, Issue.8
, pp. 656-662
-
-
Andersen, P.1
Doherty, T.M.2
-
23
-
-
0035937258
-
An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase
-
Anderson D.H., Harth G., Horwitz M.A., and Eisenberg D. An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase. J Mol Biol 307 March 23 (2) (2001) 671-681
-
(2001)
J Mol Biol
, vol.307
, Issue.March 23 2
, pp. 671-681
-
-
Anderson, D.H.1
Harth, G.2
Horwitz, M.A.3
Eisenberg, D.4
-
24
-
-
0242268398
-
Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system
-
Stanley S.A., Raghavan S., Hwang W.W., and Cox J.S. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci USA 100 October 28 (22) (2003) 13001-13006
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.October 28 22
, pp. 13001-13006
-
-
Stanley, S.A.1
Raghavan, S.2
Hwang, W.W.3
Cox, J.S.4
-
25
-
-
0033151975
-
HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens
-
Thole J.E., Janson A.A., Cornelisse Y., Schreuder G.M., Wieles B., Naafs B., et al. HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens. J Immunol 162 June 1 (11) (1999) 6912-6918
-
(1999)
J Immunol
, vol.162
, Issue.June 1 11
, pp. 6912-6918
-
-
Thole, J.E.1
Janson, A.A.2
Cornelisse, Y.3
Schreuder, G.M.4
Wieles, B.5
Naafs, B.6
-
26
-
-
16044372353
-
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
-
Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2 8 (1996) 893-898
-
(1996)
Nat Med
, vol.2
, Issue.8
, pp. 893-898
-
-
Huygen, K.1
Content, J.2
Denis, O.3
Montgomery, D.L.4
Yawman, A.M.5
Deck, R.R.6
-
27
-
-
0034040571
-
Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen
-
Olsen A.W., Hansen P.R., Holm A., and Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 30 6 (2000) 1724-1732
-
(2000)
Eur J Immunol
, vol.30
, Issue.6
, pp. 1724-1732
-
-
Olsen, A.W.1
Hansen, P.R.2
Holm, A.3
Andersen, P.4
-
28
-
-
0033979229
-
ESAT-6 subunit vaccination against Mycobacterium tuberculosis
-
Brandt L., Elhay M., Rosenkrands I., Lindblad E.B., and Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 68 2 (2000) 791-795
-
(2000)
Infect Immun
, vol.68
, Issue.2
, pp. 791-795
-
-
Brandt, L.1
Elhay, M.2
Rosenkrands, I.3
Lindblad, E.B.4
Andersen, P.5
-
29
-
-
0035055282
-
Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
-
Olsen A.W., van Pinxteren L.A.H., Okkels L.M., Rasmussen P.B., and Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Infect Immun 69 5 (2001) 2773-2778
-
(2001)
Infect Immun
, vol.69
, Issue.5
, pp. 2773-2778
-
-
Olsen, A.W.1
van Pinxteren, L.A.H.2
Okkels, L.M.3
Rasmussen, P.B.4
Andersen, P.5
-
30
-
-
0036263333
-
Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis
-
Doherty T.M., Olsen A.W., van Pinxteren L., and Andersen P. Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis. Infect Immun 70 6 (2002) 3111-3121
-
(2002)
Infect Immun
, vol.70
, Issue.6
, pp. 3111-3121
-
-
Doherty, T.M.1
Olsen, A.W.2
van Pinxteren, L.3
Andersen, P.4
-
31
-
-
4644235020
-
Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model
-
Olsen A.W., Williams A., Okkels L.M., Hatch G., and Andersen P. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 72 10 (2004) 6148-6150
-
(2004)
Infect Immun
, vol.72
, Issue.10
, pp. 6148-6150
-
-
Olsen, A.W.1
Williams, A.2
Okkels, L.M.3
Hatch, G.4
Andersen, P.5
-
32
-
-
20144362100
-
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
-
Langermans J.A., Doherty T.M., Vervenne R.A., van der Laan T., Lyashchenko K., Greenwald R., et al. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23 April 15 (21) (2005) 2740-2750
-
(2005)
Vaccine
, vol.23
, Issue.April 15 21
, pp. 2740-2750
-
-
Langermans, J.A.1
Doherty, T.M.2
Vervenne, R.A.3
van der Laan, T.4
Lyashchenko, K.5
Greenwald, R.6
-
33
-
-
0028918767
-
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants
-
Douce G., Turcotte C., Cropley I., Roberts M., Pizza M., Domenghini M., et al. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci USA 92 February 28 (5) (1995) 1644-1648
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, Issue.February 28 5
, pp. 1644-1648
-
-
Douce, G.1
Turcotte, C.2
Cropley, I.3
Roberts, M.4
Pizza, M.5
Domenghini, M.6
-
34
-
-
0035885007
-
CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen
-
Mowat A.M., Donachie A.M., Jagewall S., Schon K., Lowenadler B., Dalsgaard K., et al. CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen. J Immunol 167 September 15 (6) (2001) 3398-3405
-
(2001)
J Immunol
, vol.167
, Issue.September 15 6
, pp. 3398-3405
-
-
Mowat, A.M.1
Donachie, A.M.2
Jagewall, S.3
Schon, K.4
Lowenadler, B.5
Dalsgaard, K.6
-
35
-
-
0019407618
-
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
-
Hoiseth S.K., and Stocker B.A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291 May 21 (5812) (1981) 238-239
-
(1981)
Nature
, vol.291
, Issue.May 21 5812
, pp. 238-239
-
-
Hoiseth, S.K.1
Stocker, B.A.2
-
36
-
-
0031931453
-
B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis
-
Harboe M., Malin A.S., Dockrell H.S., Wiker H.G., Ulvund G., Holm A., et al. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun 66 2 (1998) 717-723
-
(1998)
Infect Immun
, vol.66
, Issue.2
, pp. 717-723
-
-
Harboe, M.1
Malin, A.S.2
Dockrell, H.S.3
Wiker, H.G.4
Ulvund, G.5
Holm, A.6
-
37
-
-
15544371478
-
Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains
-
Husseiny M.I., and Hensel M. Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains. Infect Immun 73 3 (2005) 1598-1605
-
(2005)
Infect Immun
, vol.73
, Issue.3
, pp. 1598-1605
-
-
Husseiny, M.I.1
Hensel, M.2
-
38
-
-
0034612342
-
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
-
Datsenko K.A., and Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97 June 6 (12) (2000) 6640-6645
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, Issue.June 6 12
, pp. 6640-6645
-
-
Datsenko, K.A.1
Wanner, B.L.2
-
40
-
-
0034442696
-
Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin
-
Chambers M.A., Williams A., Gavier-Widen D., Whelan A., Hall G., Marsh P.D., et al. Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin. Infect Immun 68 12 (2000) 7094-7099
-
(2000)
Infect Immun
, vol.68
, Issue.12
, pp. 7094-7099
-
-
Chambers, M.A.1
Williams, A.2
Gavier-Widen, D.3
Whelan, A.4
Hall, G.5
Marsh, P.D.6
-
41
-
-
20144389346
-
Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis
-
Williams A., Hatch G.J., Clark S.O., Gooch K.E., Hatch K.A., Hall G.A., et al. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinburgh, Scotland) 85 January-March (1-2) (2005) 29-38
-
(2005)
Tuberculosis (Edinburgh, Scotland)
, vol.85
, Issue.January-March 1-2
, pp. 29-38
-
-
Williams, A.1
Hatch, G.J.2
Clark, S.O.3
Gooch, K.E.4
Hatch, K.A.5
Hall, G.A.6
-
42
-
-
0033823019
-
Survival of mycobacterial species in aerosols generated from artificial saliva
-
Lever M.S., Williams A., and Bennett A.M. Survival of mycobacterial species in aerosols generated from artificial saliva. Lett Appl Microbiol 31 3 (2000) 238-241
-
(2000)
Lett Appl Microbiol
, vol.31
, Issue.3
, pp. 238-241
-
-
Lever, M.S.1
Williams, A.2
Bennett, A.M.3
-
43
-
-
0034116071
-
Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers
-
Angelakopoulos H., and Hohmann E.L. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 68 4 (2000) 2135-2141
-
(2000)
Infect Immun
, vol.68
, Issue.4
, pp. 2135-2141
-
-
Angelakopoulos, H.1
Hohmann, E.L.2
-
44
-
-
0032750184
-
Live attenuated Salmonella: a paradigm of mucosal vaccines
-
Sirard J.C., Niedergang F., and Kraehenbuhl J.P. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol Rev 171 (1999) 5-26
-
(1999)
Immunol Rev
, vol.171
, pp. 5-26
-
-
Sirard, J.C.1
Niedergang, F.2
Kraehenbuhl, J.P.3
-
46
-
-
0034014963
-
Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium
-
Allen J.S., Dougan G., and Strugnell R.A. Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium. FEMS Immunol Med Microbiol 27 4 (2000) 275-281
-
(2000)
FEMS Immunol Med Microbiol
, vol.27
, Issue.4
, pp. 275-281
-
-
Allen, J.S.1
Dougan, G.2
Strugnell, R.A.3
-
47
-
-
0031081681
-
Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles
-
Challacombe S.J., Rahman D., and O'Hagan D.T. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles. Vaccine 15 2 (1997) 169-175
-
(1997)
Vaccine
, vol.15
, Issue.2
, pp. 169-175
-
-
Challacombe, S.J.1
Rahman, D.2
O'Hagan, D.T.3
-
48
-
-
0028385269
-
Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens
-
Ruedl C., Fruhwirth M., Wick G., and Wolf H. Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens. Clin Diagn Lab Immunol 1 2 (1994) 150-154
-
(1994)
Clin Diagn Lab Immunol
, vol.1
, Issue.2
, pp. 150-154
-
-
Ruedl, C.1
Fruhwirth, M.2
Wick, G.3
Wolf, H.4
-
49
-
-
0026071140
-
Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine
-
Forrest B.D., LaBrooy J.T., Robinson P., Dearlove C.E., and Shearman D.J. Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine. Infect Immun 59 3 (1991) 1206-1209
-
(1991)
Infect Immun
, vol.59
, Issue.3
, pp. 1206-1209
-
-
Forrest, B.D.1
LaBrooy, J.T.2
Robinson, P.3
Dearlove, C.E.4
Shearman, D.J.5
-
50
-
-
0034017763
-
Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG
-
Hess J., Grode L., Hellwig J., Conradt P., Gentschev I., Goebel W., et al. Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG. FEMS Immunol Med Microbiol 27 4 (2000) 283-289
-
(2000)
FEMS Immunol Med Microbiol
, vol.27
, Issue.4
, pp. 283-289
-
-
Hess, J.1
Grode, L.2
Hellwig, J.3
Conradt, P.4
Gentschev, I.5
Goebel, W.6
-
51
-
-
0035898950
-
Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA
-
Mollenkopf H.J., Groine-Triebkorn D., Andersen P., Hess J., and Kaufmann S.H.E. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine 19 July 16 (28-29) (2001) 4028-4035
-
(2001)
Vaccine
, vol.19
, Issue.July 16 28-29
, pp. 4028-4035
-
-
Mollenkopf, H.J.1
Groine-Triebkorn, D.2
Andersen, P.3
Hess, J.4
Kaufmann, S.H.E.5
-
52
-
-
0642342151
-
Development of attenuated Salmonella strains that express heterologous antigens
-
Bowe F., Pickard D.J., Anderson R.J., Londono-Arcila P., and Dougan G. Development of attenuated Salmonella strains that express heterologous antigens. Methods Mol Med 87 (2003) 83-100
-
(2003)
Methods Mol Med
, vol.87
, pp. 83-100
-
-
Bowe, F.1
Pickard, D.J.2
Anderson, R.J.3
Londono-Arcila, P.4
Dougan, G.5
-
53
-
-
0036085692
-
Prime-boost immunization strategies for infectious diseases
-
McShane H. Prime-boost immunization strategies for infectious diseases. Curr Opin Mol Ther 4 1 (2002) 23-27
-
(2002)
Curr Opin Mol Ther
, vol.4
, Issue.1
, pp. 23-27
-
-
McShane, H.1
-
54
-
-
20444444975
-
Prime-boost immunisation strategies for tuberculosis
-
McShane H., and Hill A. Prime-boost immunisation strategies for tuberculosis. Microbes Infect 7 5-6 (2005) 962-967
-
(2005)
Microbes Infect
, vol.7
, Issue.5-6
, pp. 962-967
-
-
McShane, H.1
Hill, A.2
-
55
-
-
0024353079
-
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties
-
Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
-
(1989)
Annu Rev Immunol
, vol.7
, pp. 145-173
-
-
Mosmann, T.R.1
Coffman, R.L.2
-
56
-
-
0028903154
-
Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract
-
Klimpel G.R., Asuncion M., Haithcoat J., and Niesel D.W. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect Immun 63 3 (1995) 1134-1137
-
(1995)
Infect Immun
, vol.63
, Issue.3
, pp. 1134-1137
-
-
Klimpel, G.R.1
Asuncion, M.2
Haithcoat, J.3
Niesel, D.W.4
-
57
-
-
0033826580
-
Is the development of a new tuberculosis vaccine possible?
-
Kaufmann S.H. Is the development of a new tuberculosis vaccine possible?. Nat Med 6 9 (2000) 955-960
-
(2000)
Nat Med
, vol.6
, Issue.9
, pp. 955-960
-
-
Kaufmann, S.H.1
-
58
-
-
0027360333
-
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
-
Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 December 1 (6) (1993) 2249-2254
-
(1993)
J Exp Med
, vol.178
, Issue.December 1 6
, pp. 2249-2254
-
-
Flynn, J.L.1
Chan, J.2
Triebold, K.J.3
Dalton, D.K.4
Stewart, T.A.5
Bloom, B.R.6
-
60
-
-
0034981752
-
The role of gamma interferon in antimicrobial immunity
-
Shtrichman R., and Samuel C.E. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 4 3 (2001) 251-259
-
(2001)
Curr Opin Microbiol
, vol.4
, Issue.3
, pp. 251-259
-
-
Shtrichman, R.1
Samuel, C.E.2
-
61
-
-
0032213010
-
Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria
-
Ottenhoff T.H., Kumararatne D., and Casanova J.L. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 19 11 (1998) 491-494
-
(1998)
Immunol Today
, vol.19
, Issue.11
, pp. 491-494
-
-
Ottenhoff, T.H.1
Kumararatne, D.2
Casanova, J.L.3
-
62
-
-
0030639088
-
T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection
-
Murray P.J., Wang L., Onufryk C., Tepper R.I., and Young R.A. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 158 January 1 (1) (1997) 315-321
-
(1997)
J Immunol
, vol.158
, Issue.January 1 1
, pp. 315-321
-
-
Murray, P.J.1
Wang, L.2
Onufryk, C.3
Tepper, R.I.4
Young, R.A.5
-
63
-
-
0034327167
-
Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues
-
van Ginkel F.W., Jackson R.J., Yuki Y., and McGhee J.R. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 165 November 1 (9) (2000) 4778-4782
-
(2000)
J Immunol
, vol.165
, Issue.November 1 9
, pp. 4778-4782
-
-
van Ginkel, F.W.1
Jackson, R.J.2
Yuki, Y.3
McGhee, J.R.4
-
64
-
-
27144456562
-
Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines
-
Armstrong M.E., Lavelle E.C., Loscher C.E., Lynch M.A., and Mills K.H. Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines. J Infect Dis 192 November 1 (9) (2005) 1628-1633
-
(2005)
J Infect Dis
, vol.192
, Issue.November 1 9
, pp. 1628-1633
-
-
Armstrong, M.E.1
Lavelle, E.C.2
Loscher, C.E.3
Lynch, M.A.4
Mills, K.H.5
-
65
-
-
1342268107
-
Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy
-
Couch R.B. Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. N Engl J Med 350 February 26 (9) (2004) 860-861
-
(2004)
N Engl J Med
, vol.350
, Issue.February 26 9
, pp. 860-861
-
-
Couch, R.B.1
-
66
-
-
1342268100
-
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
-
Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 350 February 26 (9) (2004) 896-903
-
(2004)
N Engl J Med
, vol.350
, Issue.February 26 9
, pp. 896-903
-
-
Mutsch, M.1
Zhou, W.2
Rhodes, P.3
Bopp, M.4
Chen, R.T.5
Linder, T.6
-
67
-
-
0024346776
-
Pathogenesis and immunity in murine salmonellosis
-
Hsu H.S. Pathogenesis and immunity in murine salmonellosis. Microbiol Rev 53 4 (1989) 390-409
-
(1989)
Microbiol Rev
, vol.53
, Issue.4
, pp. 390-409
-
-
Hsu, H.S.1
-
68
-
-
0015848636
-
Interactions between macrophages of guinea pigs and salmonellae. 3. Bactericidal action and cytophilic antibodies of macrophages of infected guinea pigs
-
Hsu H.S., and Mayo D.R. Interactions between macrophages of guinea pigs and salmonellae. 3. Bactericidal action and cytophilic antibodies of macrophages of infected guinea pigs. Infect Immun 8 2 (1973) 165-172
-
(1973)
Infect Immun
, vol.8
, Issue.2
, pp. 165-172
-
-
Hsu, H.S.1
Mayo, D.R.2
-
69
-
-
0015324214
-
Acquired resistance to and comparative virulence of Salmonella typhimurium demonstrated by cutaneous lesions in guinea pigs
-
Hsu H.S., and Piper V.M. Acquired resistance to and comparative virulence of Salmonella typhimurium demonstrated by cutaneous lesions in guinea pigs. J Reticuloendoth Soc 11 4 (1972) 343-357
-
(1972)
J Reticuloendoth Soc
, vol.11
, Issue.4
, pp. 343-357
-
-
Hsu, H.S.1
Piper, V.M.2
-
70
-
-
0014311180
-
Interactions between macrophages of guinea pigs and Salmonellae. I. Fate of Salmonella typhimurium within macrophages of normal guinea pigs
-
Hsu H.S., and Radcliffe A.S. Interactions between macrophages of guinea pigs and Salmonellae. I. Fate of Salmonella typhimurium within macrophages of normal guinea pigs. J Bacteriol 96 1 (1968) 191-197
-
(1968)
J Bacteriol
, vol.96
, Issue.1
, pp. 191-197
-
-
Hsu, H.S.1
Radcliffe, A.S.2
-
71
-
-
0017717279
-
Interactions between salmonellae and macrophages of guinea pigs. IV. Relationship between migration inhibition and antibacterial action of macrophages
-
Mayo D.R., Hsu H.S., and Lim F. Interactions between salmonellae and macrophages of guinea pigs. IV. Relationship between migration inhibition and antibacterial action of macrophages. Infect Immun 18 1 (1977) 52-59
-
(1977)
Infect Immun
, vol.18
, Issue.1
, pp. 52-59
-
-
Mayo, D.R.1
Hsu, H.S.2
Lim, F.3
-
72
-
-
0015955913
-
Effect of kanamycin on the fate of Salmonella enteritidis within cultured macrophages of guinea pigs
-
Rhodes M.W., and Hsu H.S. Effect of kanamycin on the fate of Salmonella enteritidis within cultured macrophages of guinea pigs. J Reticuloendoth Soc 15 1 (1974) 1-12
-
(1974)
J Reticuloendoth Soc
, vol.15
, Issue.1
, pp. 1-12
-
-
Rhodes, M.W.1
Hsu, H.S.2
-
73
-
-
70350746623
-
Interactions between macrophages of guinea pigs and Salmonellae. II. Phagocytosis of Salmonella typhimurium by macrophages of normal guinea pigs
-
Wells P.S., and Hsu H.S. Interactions between macrophages of guinea pigs and Salmonellae. II. Phagocytosis of Salmonella typhimurium by macrophages of normal guinea pigs. Infect Immun 2 2 (1970) 145-149
-
(1970)
Infect Immun
, vol.2
, Issue.2
, pp. 145-149
-
-
Wells, P.S.1
Hsu, H.S.2
|